Suppression of anti-tumor immunity by Treg-derived TGF-β1.Lucas, Sophie(2019) 2019 European Society for Immunodeficiencies (ESID) — Location: Brussels, Belgium (18.September.2019)
FilesNo attached file found for this publication.DetailsAuthorsLucas, SophieUCLouvainAuthorAbstractSuppression of anti-tumor immunity by Treg-derived TGF-β1.Show moreAffiliationsUCLouvainSSS/DDUV/GECE - Génétique cellulaireShow moreCitations APA Chicago FWB Lucas, S. (2019). Suppression of anti-tumor immunity by Treg-derived TGF-β1. 2019 European Society for Immunodeficiencies (ESID), Brussels, Belgium. https://hdl.handle.net/2078.5/110950